Shrinking lung syndrome caused by lupus myopathy

QJM: An International Journal of Medicine

Volumn 104, Issue 3, 2011, Pages 259-262

  Perez de Llano L A ^a   Castro Anon O ^a   Lopez M J ^a   Escalona, E ^a   Teijeira, S ^b   Sanchez Andrade A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; PREDNISONE; RITUXIMAB; SALBUTAMOL; STEROID; THEOPHYLLINE;

ADULT; ALOPECIA; ARTHRALGIA; ARTICLE; ASSISTED VENTILATION; ASTHENIA; BREATHING MUSCLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DIAPHRAGM MUSCLE; DYSPHAGIA; FEMALE; FORCED EXPIRATORY VOLUME; GLOMERULONEPHRITIS; HUMAN; KIDNEY BIOPSY; LIVEDO RETICULARIS; LUNG DISEASE; LUPUS MYOPATHY; MICROCYTIC ANEMIA; MOUTH ULCER; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MYOPATHY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PULSE OXIMETRY; SHRINKING LUNG SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 79953792506     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq095     Document Type: Article

References (12)

1. Warrington KJ, Moder KG, Brutinel WM. Shrinking lung syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000; 75:467-72.
2. Karim MY, Miranda LC, Tench CM, Gordon PA, D'cruz DP, Khamashta MA, et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002; 31:289-98.
3. Toya SP, Tzelepis GE. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review. Semin Arthritis Rheum 2009; 39:30-7.
4. Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983; 84:170-5.
5. Wilcox PG, Stein HB, Clarke SD, Paré PD, Pardy RL. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988; 93:352-8.
6. Hawkins P, Davison AG, Dasgupta B, Moxham J. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001; 56:329-30.
7. Laroche CM, Mulvey DA, Hawkins PN, Walport MJ, Strickland B, Moxham J, et al. Diaphragm strength in the shrinking lung syndrome in systemic lupus erythematosus. Q J Med 1989; 71:429-39.
8. Gibson CJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977; 63:926-32.
9. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE: a clinical pathologic study. J Rheumatol 1983; 10:973-6.
10. Walz-Leblanc BAE, Urowitz MB, Gladman DD, Hanly PJ. Shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. J Rheumatol 1992; 19:1970-2.
11. Van Veen S, Peters AJ, Sterk PJ, Breedveld FC. Shrinking lung syndrome in SLE, treatment with theophylline. Clin Rheumatol 1993; 12:462-5.
12. Muñoz-Rodriguez FJ, Font J, Badia JR, Miret C, Barberà JA, Cervera R, et al. Shrinking lung syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist. Lupus 1997; 6: 412-4.